Require greater diversity in clinical trials

Diana DeGette and Rep. Fred Upton proposed requiring greater diversity in clinical trials. They said the change would help ensure drugs and treatments approved for use in the United States are safe and effective for a greater portion of the population.

Context: Joint proposal in Cures 2.0, introduced in 2021; the source does not specify how diversity would be required.

In their own words

require greater diversity in clinical trials

The source

Diana DeGette: Developing New Cures

Published: Original date not established; campaign context manually checked
Retrieved: 11/10/2026